Table of Content

1 Liver Fibrosis Drug Market Introduction and Overview
1.1 Liver Fibrosis Drug Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Liver Fibrosis Drug Revenue and Market Share by Manufacturer
2.2 Manufacturers Liver Fibrosis Drug Production Sites, Area Served, Product Types
2.3 Liver Fibrosis Drug Market Competitive Situation and Trends
2.3.1 Liver Fibrosis Drug Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2024
2.3.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 Bird Rock Bio Inc.
3.1.1 Bird Rock Bio Inc. Company Profile
3.1.2 Liver Fibrosis Drug Product Overview
3.1.3 Bird Rock Bio Inc. Liver Fibrosis Drug Market Performance (2019-2024)
3.1.4 Bird Rock Bio Inc. Business Overview
3.2 Bristol-Myers Squibb Company
3.2.1 Bristol-Myers Squibb Company Company Profile
3.2.2 Liver Fibrosis Drug Product Overview
3.2.3 Bristol-Myers Squibb Company Liver Fibrosis Drug Market Performance (2019-2024)
3.2.4 Bristol-Myers Squibb Company Business Overview
3.3 Celgene Corporation
3.3.1 Celgene Corporation Company Profile
3.3.2 Liver Fibrosis Drug Product Overview
3.3.3 Celgene Corporation Liver Fibrosis Drug Market Performance (2019-2024)
3.3.4 Celgene Corporation Business Overview
3.4 Dicerna Pharmaceuticals Inc.
3.4.1 Dicerna Pharmaceuticals Inc. Company Profile
3.4.2 Liver Fibrosis Drug Product Overview
3.4.3 Dicerna Pharmaceuticals Inc. Liver Fibrosis Drug Market Performance (2019-2024)
3.4.4 Dicerna Pharmaceuticals Inc. Business Overview
3.5 Digna Biotech
3.5.1 Digna Biotech Company Profile
3.5.2 Liver Fibrosis Drug Product Overview
3.5.3 Digna Biotech Liver Fibrosis Drug Market Performance (2019-2024)
3.5.4 Digna Biotech Business Overview
3.6 S.L.
3.6.1 S.L. Company Profile
3.6.2 Liver Fibrosis Drug Product Overview
3.6.3 S.L. Liver Fibrosis Drug Market Performance (2019-2024)
3.6.4 S.L. Business Overview
3.7 Genfit SA
3.7.1 Genfit SA Company Profile
3.7.2 Liver Fibrosis Drug Product Overview
3.7.3 Genfit SA Liver Fibrosis Drug Market Performance (2019-2024)
3.7.4 Genfit SA Business Overview
3.8 Gilead Sciences Inc.
3.8.1 Gilead Sciences Inc. Company Profile
3.8.2 Liver Fibrosis Drug Product Overview
3.8.3 Gilead Sciences Inc. Liver Fibrosis Drug Market Performance (2019-2024)
3.8.4 Gilead Sciences Inc. Business Overview
3.9 GNI Group Ltd.
3.9.1 GNI Group Ltd. Company Profile
3.9.2 Liver Fibrosis Drug Product Overview
3.9.3 GNI Group Ltd. Liver Fibrosis Drug Market Performance (2019-2024)
3.9.4 GNI Group Ltd. Business Overview
3.10 HEC Pharm Co. Ltd
3.10.1 HEC Pharm Co. Ltd Company Profile
3.10.2 Liver Fibrosis Drug Product Overview
3.10.3 HEC Pharm Co. Ltd Liver Fibrosis Drug Market Performance (2019-2024)
3.10.4 HEC Pharm Co. Ltd Business Overview
3.11 Dr. Falk Pharma GmbH
3.11.1 Dr. Falk Pharma GmbH Company Profile
3.11.2 Liver Fibrosis Drug Product Overview
3.11.3 Dr. Falk Pharma GmbH Liver Fibrosis Drug Market Performance (2019-2024)
3.11.4 Dr. Falk Pharma GmbH Business Overview
3.12 LG Life Science LTD.
3.12.1 LG Life Science LTD. Company Profile
3.12.2 Liver Fibrosis Drug Product Overview
3.12.3 LG Life Science LTD. Liver Fibrosis Drug Market Performance (2019-2024)
3.12.4 LG Life Science LTD. Business Overview
4 Global Liver Fibrosis Drug Historical and Forecast Market Analysis by Type
4.1 Global Liver Fibrosis Drug Revenue and Market Share by Type
4.2 Global Liver Fibrosis Drug Revenue Market Forecast by Type (2024-2030)
5 Global Liver Fibrosis Drug Historical and Forecast Market Analysis by Application
5.1 Global Liver Fibrosis Drug Revenue Market Share by Application (2019-2024)
5.2 Liver Fibrosis Drug Revenue Market Forecast by Application (2024-2030)
6 Global Market Growth Trends Analysis
6.1 Global Liver Fibrosis Drug Market Size & Forecast (2019-2030)
6.2 Liver Fibrosis Drug Growth Trends Analysis by Regions
6.2.1 Liver Fibrosis Drug Market Size by Regions: 2019 VS 2024 VS 2030
6.2.2 Liver Fibrosis Drug Historic Revenue Market Size by Regions (2019-2024)
6.2.3 Liver Fibrosis Drug Forecasted Revenue Market Size by Regions (2024-2030)
6.2.4 North America Liver Fibrosis Drug Market Size & Forecast (2019-2030)
6.2.5 Europe Liver Fibrosis Drug Market Size & Forecast (2019-2030)
6.2.6 China Liver Fibrosis Drug Market Size & Forecast (2019-2030)
6.2.7 Japan Liver Fibrosis Drug Market Size & Forecast (2019-2030)
6.2.8 Korea Liver Fibrosis Drug Market Size & Forecast (2019-2030)
6.2.9 Southeast Asia Liver Fibrosis Drug Market Size & Forecast (2019-2030)
6.2.10 India Liver Fibrosis Drug Market Size & Forecast (2019-2030)
6.2.11 South America Liver Fibrosis Drug Market Size & Forecast (2019-2030)
6.2.12 Middle East & Africa Liver Fibrosis Drug Market Size & Forecast (2019-2030)
7 North America
7.1 North America Liver Fibrosis Drug Revenue by Players
7.2 North America Liver Fibrosis Drug Revenue by Types
7.3 North America Liver Fibrosis Drug Revenue by Applications
7.4 North America Liver Fibrosis Drug Revenue, Gross and Gross Margin (2019-2024)
7.5 North America PEST Analysis
8 Europe
8.1 Europe Liver Fibrosis Drug Revenue by Players
8.2 Europe Liver Fibrosis Drug Revenue by Types
8.3 Europe Liver Fibrosis Drug Revenue by Applications
8.4 Europe Liver Fibrosis Drug Revenue, Gross and Gross Margin (2019-2024)
8.5 Europe PEST Analysis
9 China
9.1 China Liver Fibrosis Drug Revenue by Players
9.2 China Liver Fibrosis Drug Revenue by Types
9.3 China Liver Fibrosis Drug Revenue by Applications
9.4 China Liver Fibrosis Drug Revenue, Gross and Gross Margin (2019-2024)
9.5 China PEST Analysis
10 Japan
10.1 Japan Liver Fibrosis Drug Revenue by Players
10.2 Japan Liver Fibrosis Drug Revenue by Types
10.3 Japan Liver Fibrosis Drug Revenue by Applications
10.4 Japan Liver Fibrosis Drug Revenue, Gross and Gross Margin (2019-2024)
10.5 Japan PEST Analysis
11 Korea
11.1 Korea Liver Fibrosis Drug Revenue by Players
11.2 Korea Liver Fibrosis Drug Revenue by Types
11.3 Korea Liver Fibrosis Drug Revenue by Applications
11.4 Korea Liver Fibrosis Drug Revenue, Gross and Gross Margin (2019-2024)
11.5 Korea PEST Analysis
12 Southeast Asia
12.1 Southeast Asia Liver Fibrosis Drug Revenue by Players
12.2 Southeast Asia Liver Fibrosis Drug Revenue by Types
12.3 Southeast Asia Liver Fibrosis Drug Revenue by Applications
12.4 Southeast Asia Liver Fibrosis Drug Revenue, Gross and Gross Margin (2019-2024)
12.5 Southeast Asia PEST Analysis
13 India
13.1 India Liver Fibrosis Drug Revenue by Players
13.2 India Liver Fibrosis Drug Revenue by Types
13.3 India Liver Fibrosis Drug Revenue by Applications
13.4 India Liver Fibrosis Drug Revenue, Gross and Gross Margin (2019-2024)
13.5 India PEST Analysis
14 South America
14.1 South America Liver Fibrosis Drug Revenue by Players
14.2 South America Liver Fibrosis Drug Revenue by Types
14.3 South America Liver Fibrosis Drug Revenue by Applications
14.4 South America Liver Fibrosis Drug Revenue, Gross and Gross Margin (2019-2024)
14.5 South America PEST Analysis
15 Middle East & Africa
15.1 Middle East & Africa Liver Fibrosis Drug Revenue by Players
15.2 Middle East & Africa Liver Fibrosis Drug Revenue by Types
15.3 Middle East & Africa Liver Fibrosis Drug Revenue by Applications
15.4 Middle East & Africa Liver Fibrosis Drug Revenue, Gross and Gross Margin (2019-2024)
15.5 Middle East & Africa PEST Analysis
16 Liver Fibrosis Drug Business Cost Analysis
16.1 Proportion of Business Cost Structure
16.1.1 Labor Cost
16.1.2 Operating Expenses
16.2 Liver Fibrosis Drug Industrial Chain Analysis
17 Liver Fibrosis Drug Industry Dynamic Analysis
17.1 Liver Fibrosis Drug Market Trends Analysis
17.2 Liver Fibrosis Drug Market Drivers Analysis
17.3 Liver Fibrosis Drug Market Challenges Analysis
17.4 Liver Fibrosis Drug Market Restraints Analysis
18 Research Findings and Conclusion